TCNT Sells 46,000 Ainos Shares at $2.17, Signaling Strategic Rebalance Amid Volatile Biotech Stock
TCNT’s recent Ainos share sell‑off signals tactical liquidity, not a red flag—investors should assess Ainos’ volatility and future plans before re‑valuating.
3 minutes to read